In an interview that took place at the European Society for Medical Oncology 2024 Congress in Barcelona, Spain, Timothy Yap, MBBS, PhD, medical oncologist, The University of Texas…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – Anticoagulant use may be a predictor of overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel, retrospective data suggest. The…
NEW YORK (Reuters Health) – Transplantation of hematopoietic cells from a donor with a single matched HLA haplotype, combined with post-transplant cyclophosphamide, may be a good alternative when…
NEW YORK (Reuters Health) – Patients with follicular non-Hodgkin lymphoma that has transformed into aggressive-histology lymphoma do better when treated with high-dose chemotherapy followed by autologous stem-cell transplantation…
NEW YORK (Reuters Health) – Reducing exposure to alkylating agents in patients with Hodgkin lymphoma is key to reducing the risk of developing therapy-related acute myeloid leukemia or…
NEW YORK (Reuters Health) – Agents that target the mTOR axis, which have become particularly important in the treatment of advanced renal cell carcinoma (RCC), have significant adverse…
NEW YORK (Reuters Health) – Revised guidelines on the assessment and management of reproductive complications in young female cancer survivors provide the latest evidence-based recommendations for evaluation and…
NEW YORK (Reuters Health) – Symptomatic lymphoceles that develop after retroperitoneal lymph node dissection in gynecologic cancer patients can be dealt with safely and effectively by laparoscopic lymphocele…
NEW YORK (Reuters Health) – While the risk of prostate cancer appears to be reduced in men taking dutasteride, there are indications that cancer may emerge once the…
NEW YORK (Reuters Health) – TNFerade biologic, a novel method of delivering tumor necrosis factor to tumor cells by gene transfer, does not prolong survival when added to…
NEW YORK (Reuters Health) – Patients with non-castrate metastatic prostate cancer receiving androgen deprivation therapy fare no better with the addition of docetaxel chemotherapy, a French and Belgian…
